Mass firings at the FDA have decimated divisions tasked with releasing public records generated by the agency's regulatory ...

Concern is growing among public health experts that anti-vaccine sentiments within federal and state governments may derail ...

Novavax started the week hoping the FDA would issue a full approval of its Covid vaccine. But the decision never came.

The agency is sitting on a decision to grant full approval for Novavax’s shot, days after top vaccine regulator pushed out.

In the wake of unprecedented workforce cuts at the FDA, former Commissioner Scott Gottlieb and an unnamed former CBER ...

Amid a period of great upheaval at the agency, the FDA has missed its deadline to decide on approval for Novavax’s COVID-19 ...

The U.S. Food and Drug Administration has missed its deadline for making a decision on traditional approval for Novavax's ...

As the Trump administration cuts thousands of federal jobs, some fired workers worry about health agencies' ability to ...

But with FDA action, it would be the third vaccine against COVID-19 to receive full FDA approval. Full approval would make ...

The FDA was scheduled to release its decision on Novavax’s updated, protein-based COVID-19 vaccine on April 1, but the agency ...

A person familiar with the situation told CNN that the FDA is seeking more data on the vaccine, which has been available under emergency use authorization since 2022. It was the first Covid-19 ...

The decision had been expected by April 1, but the agency now says it needs more information before moving forward.